1 |
Weiner RE, Sasso DE, Gionfriddo MA, Syrbu SI, Smilowitz HM, Vento J, et al. Early detection of bleomycin- induced lung injury in rat using indium-111-labeled antibody directed against intercellular adhesion molecule-1. J Nucl Med 1998;39:723-8.
|
2 |
Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985;59:1978-85.
|
3 |
Hobson J, Wright J, Churg A. Histochemical evidence for generation of active oxygen species on the apical surface of cigarette-smoke-exposed tracheal explants. Am J Pathol 1991;139:573-80.
|
4 |
Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985;119: 101-10.
|
5 |
Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation states: therapeutic challenges. Shock 1995;3:157-66.
|
6 |
Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Inf Dis 2003;3:359-71.
DOI
ScienceOn
|
7 |
Koksel O, Cinel I, Tamer L, Cinel L, Ozdulger A, Kanik A, et al. N-acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury. Pulm Pharmacol Ther 2004;17:263-70.
DOI
ScienceOn
|
8 |
Julien M, Hoeffel JM, Flick MR. Oleic acid lung injury in sheep. J Appl Physiol 1986;60:433-40.
DOI
|
9 |
Lee YM, Kim BY, Park YY. Role of the PLA2-activated neutrophilic oxidative stress in oleic acid-induced acute lung injury. Tuberc Respir Dis 2010;68:55-61.
DOI
ScienceOn
|
10 |
Shmelzer Z, Haddad N, Admon E, Pessach I, Leto TL, Eitan-Hazan Z, et al. Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J Cell Biol 2003; 162:683-92.
DOI
ScienceOn
|
11 |
Pruzanski W, Vadas P. Phospholipase A2: a mediator between proximal and distal effectors of inflammation. Immunol Today 1991;12:143-6.
|
12 |
Arbibe L, Vial D, Touqui L. Phospholipase A2 and acute respiratory distress syndrome. Prog Surg 1997;24: 79-87.
DOI
|
13 |
Dana R, Malech HL, Levy R. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem J 1994;297: 217-23.
|
14 |
Ware LB. Advances in the pathogenesis and treatment of the acute respiratory distress syndrome. Clin Pul Med 2003;10:208-18.
DOI
ScienceOn
|
15 |
Lucas KK, Dennis EA. The ABC's of Group IV cytosolic phospholipase A2. Biochim Biophys Acta 2004;1636: 213-8
DOI
ScienceOn
|
16 |
Huang HC, Shieh CC, Yu WL, Cheng KC, Chen CC, Chang ST, et al. Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries. Respirology 2008;13:47-52.
DOI
ScienceOn
|
17 |
Wang JP, Raung SL, Huang LJ, Kuo SC. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils. Biochem Pharmacol 1998;56:1505-14.
DOI
ScienceOn
|
18 |
Stommer P, Steinmann U. Phospholipase A2 induced diffuse alveolar damage: effect of indomethacin and dexamethasone upon morphology and plasma-histamine level. Klin Wochenschr 1989;67:171-6.
DOI
|
19 |
Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 2009;1792:941-53.
|
20 |
Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME. Phospholipases A2 and platelet-activating- factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005;33:772-9.
DOI
ScienceOn
|
21 |
Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006;1761:1246-59.
DOI
ScienceOn
|
22 |
Wheeler DS. Phospholipase A2 and acute lung injury: it's just not that simple. Crit Care Med 2005;33:904-5.
DOI
ScienceOn
|
23 |
Karagiorga G, Nakos G, Galiatsou E, Lekka ME. Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med 2006;32:116-23.
DOI
ScienceOn
|
24 |
Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 1997;272:16709-12.
DOI
ScienceOn
|
25 |
Nagase T, Uozumi N, Ishii S, Kume K, Izumi T, Ouchi Y, et al. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol 2000;1:42-6.
DOI
ScienceOn
|
26 |
Magrioti V, Kokotos G. Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. Expert Opin Ther Pat 2010;20: 1-18.
DOI
ScienceOn
|
27 |
Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res 2006;45:487-510.
DOI
ScienceOn
|
28 |
Kramer RM, Sharp JD. Structure, function and regulation of -sensitive cytosolic phospholipase A2 ( ). FEBS Lett 1997;410:49-53.
DOI
ScienceOn
|